Knowledge Zone
Brief summaries of the market access landscape for medical technologies and in-vitro diagnostic tests in European countries
Recent news and posts
New procedure and diagnostic codes added to the private reimbursement schedule in England
On August 10, 2023, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclatures for private payers in England, published Bulletins 191 and 087 with changes to be implemented no later than October 6, 2023.
Four new codes concerning urogynecology procedures were introduced. Some examples are provided below:
- P2430 Robotic assisted laparoscopic sacrocolpopexy +/- ureterolysis, using mesh;
- P2432 Sacrocolpopexy (including laparoscopic) +/- ureterolysis, using mesh.
Furthermore, one new procedure code was added in the neuromodulation field.
Six new codes were introduced for in-vitro diagnostic tests. As an example, 0046G “MRD Genomic Sequencing Solid Tumours”.
See the full details here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.